Recent Quarter Total Invested
$3.24 M
Recent Quarter Institutional Ownership Percentage
7.66%
Total Invested of Last Quarter
$5.72 M
Ownership Percentage of Last Quarter
14.85%
Lexaria Bioscience Corp. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
INVENOMIC CAPITAL MANAGEMENT LP | 11/14/2024 | 475,773 | $1.45 M | -7.36% | 3.43% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 150,391 | $458,794 | 31.02% | 1.09% |
GENTRUST, LLC | 11/12/2024 | 60,000 | $183,000 | 0.00% | 0.43% |
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | 10/18/2024 | 44,900 | $136,945 | -7.99% | 0.32% |
STATE STREET CORP | 11/14/2024 | 39,301 | $119,868 | 0.00% | 0.28% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 27,445 | $83,707 | 100.00% | 0.20% |
WELCH GROUP, LLC | 10/24/2024 | 24,000 | $73,200 | 0.00% | 0.17% |
MORGAN STANLEY | 11/14/2024 | 22,982 | $70,095 | 0.00% | 0.17% |
XTX TOPCO LTD | 11/14/2024 | 18,626 | $56,809 | 47.80% | 0.13% |
BANK OF MONTREAL /CAN/ | 11/13/2024 | 14,000 | $42,280 | 100.00% | 0.10% |
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 10/24/2024 | 13,823 | $42,160 | 0.00% | 0.10% |
HIGHTOWER ADVISORS, LLC | 11/14/2024 | 13,023 | $40,000 | 100.00% | 0.09% |
HRT FINANCIAL LP | 11/12/2024 | 10,257 | $31,000 | 100.00% | 0.07% |
ROYAL BANK OF CANADA | 11/14/2024 | 7,283 | $22,000 | 0.00% | 0.05% |
OAKWORTH CAPITAL, INC. | 10/21/2024 | 5,000 | $15,250 | 0.00% | 0.04% |
WELLS FARGO & COMPANY/MN | 11/13/2024 | 2,500 | $7,625 | -24.24% | 0.02% |
ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 2,290 | $6,984 | 0.00% | 0.02% |
ASPIRE PRIVATE CAPITAL, LLC | 10/25/2024 | 400 | $1,220 | 0.00% | 0.00% |
FARTHER FINANCE ADVISORS, LLC | 10/29/2024 | 166 | $506 | 0.00% | 0.00% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 115 | $351 | 19.79% | 0.00% |
SOUND INCOME STRATEGIES, LLC | 10/10/2024 | 22 | $68 | 100.00% | 0.00% |
GABLES CAPITAL MANAGEMENT INC. | 10/25/2024 | 13 | $40 | 0.00% | 0.00% |
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 11/12/2024 | 9 | $27 | 100.00% | 0.00% |
1832 ASSET MANAGEMENT L.P. | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
TORONTO DOMINION BANK | 11/18/2024 | 0 | $0 | -100.00% | 0.00% |
RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
MATHER GROUP, LLC. | 10/07/2024 | 0 | $0 | -100.00% | 0.00% |
ALLWORTH FINANCIAL LP | 10/23/2024 | 0 | $0 | -100.00% | 0.00% |
ARMISTICE CAPITAL, LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
Lexaria Bioscience Corp.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of LEXX shares?
During the previous two years, 32 institutional investors and hedge funds held shares of Lexaria Bioscience Corp.. The most heavily invested institutionals were:
Invenomic Capital Management LP: 475,773
GEODE CAPITAL MANAGEMENT, LLC: 150,391
GenTrust, LLC: 60,000
Raymond James Financial Services Advisors, Inc.: 44,900
STATE STREET CORP: 39,301
BlackRock Funding, Inc. /DE: 27,445
-
What percentage of Lexaria Bioscience Corp. stock is owned by institutional investors?
7.66% of Lexaria Bioscience Corp. stock is owned by institutional investors.
-
How much institutional buying is happening at LEXX ?
Institutional investors have bought a total of 962,450 shares in the last 24 months. This purchase volume represents approximately $2.07 M in transactions.